Chinese battery makers are posting record profits while India still struggles to build a competitive cell manufacturing base. That contrast is the core of a Business Today analysis published this week, which frames batteries as the single toughest link in India's electric vehicle supply chain.

The report does not announce a plant closure or a new program. Its significance is diagnostic. It argues that China's cell makers have turned scale into margin, and that India's EV push cannot succeed on assembly alone without a domestic cell industry to match.

What does the profit gap actually expose?

Business Today points to China's entrenched advantages across the battery value chain: raw material processing, precursor and cathode production, and gigawatt-scale cell plants operated by tier-one suppliers serving every major OEM. Chinese producers converted that vertical grip into profitability even as cell prices fell globally.

India, by contrast, imports most of its cells. Local EV assembly depends on imported packs, which limits how much value addition New Delhi's production-linked incentive schemes can actually capture. The report treats this as the structural weakness in India's EV manufacturing ambition.

The analysis says the gap matters for policy too. Import dependence leaves Indian OEM and supplier programs exposed to supply shocks and pricing decisions made in Beijing, Seoul and Tokyo. A caveat follows every promise here: the report offers diagnosis, not a confirmed timetable for closing the gap.

What is missing from the picture?

The report's central claim rests on Chinese producers' profitability. It does not publish a full plant-by-plant reconciliation against Indian output data, so the scale of the margin gap remains an assertion to verify. Business Today also does not say which Indian cell projects are on schedule and which have slipped.

That omission matters. Announced Indian cell ventures are intentions until production data confirms them. Several programs have been disclosed with capacity targets in past policy cycles. Their current build-out status is the number readers need, and the report leaves it largely unanswered.

What should manufacturers watch next?

Three checkpoints will test whether India closes any of this gap. First, actual cell output from Indian plants under the production-linked incentive scheme, not commissioned intentions. Second, whether Chinese cell prices and profits stay high enough to keep the import route attractive. Third, any OEM decision to lock multi-year cell supply contracts with local tier-one suppliers rather than importers.

Business Today's verdict is blunt but incomplete. The profit boom in China is real. India's answer to it, so far, exists mostly on paper. Watch the first large Indian cell line to hit nameplate capacity. That milestone, and no announcement before it, will tell the story.